President Trump’s proposed tariffs on Denmark could have costly consequences for Americans relying on GLP-1 medications like Ozempic and Wegovy—and consumers are becoming increasingly concerned. While ...

The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications ... The guide linked here is the AstraZeneca brand of Byetta.

Experts are calling on the government to implement strategies that will better predict future Ozempic shortages.

Smith and Dani Blum Over a decade ago, a smattering of studies suggested that early cousins of drugs like Ozempic and Mounjaro ... sold under the brand name Victoza), had slower declines in ...

Spencer Durham can be reached at 765-454-8598, by email at [email protected] or on Twitter at @Durham_KT.

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with ...

Weight-loss drugs such as Ozempic have been a breakthrough because ... As food companies such as Nestlé launch new brands specifically targeted at GLP-1 users (its Vital Pursuit range includes ...